Figure 2 of Wistow, Mol Vis 2002; 8:205-220.


Figure 2. A novel tetraspanin, Oculospanin (Ocsp)

The complete cDNA sequence and predicted amino acid sequence, with noncoding sequence in lower case. Four predicted transmembrane helices are colored red. The peptide used to generate antiserum is shown in blue and a potential N-linked glycosylation site is colored green.

cacagaggagccagcgaacctctcccggcgcctgttctgggggctttctgttccagcgtc   60
     M  E  E  G  E  R  S  P  L  L  S  Q  E  T  A  G  Q  K  P   19
aaggATGGAGGAGGGGGAGAGGAGCCCCTTACTGTCCCAGGAAACTGCAGGCCAGAAGCC  120
  L  S  V  H  R  P  P  T  S  G  C  L  G  P  V  P  R  E  D  Q   39
CCTCTCTGTGCACAGGCCACCCACCTCAGGCTGCCTAGGTCCAGTGCCCAGGGAGGACCA  180
  A  E  A  W  G  C  S  C  C  P  P  E  T  K  H  Q  A  L  S  G   59
GGCGGAGGCCTGGGGCTGCAGCTGCTGTCCCCCGGAGACCAAGCACCAGGCCTTGAGTGG  240
  T  P  K  K  G  P  A  P  S  L  S  P  G  S  S  C  V  K  Y  L   79
CACTCCCAAGAAAGGACCAGCCCCTTCCCTCTCCCCAGGGAGCAGCTGCGTCAAGTATCT  300
  I  F  L  S  N  F  P  F  S  L  L  G  L  L  A  L  A  I  G  L   99
GATCTTCCTCTCCAACTTCCCCTTCTCCCTGCTGGGGCTGCTGGCCcTGGCCATCGGGCT  360
  W  G  L  A  V  K  G  S  L  G  S  D  L  G  G  P  L  P  T  D  119
CTGGGGCCTGGCTGTCAAGGGGTCTCTGGGAAGTGATCTGGGGGGGCCCCTGCCCACAGA  420
  P  M  L  G  L  A  L  G  G  L  V  V  S  A  A  S  L  A  G  C  139
CCCCATGCTGGGGCTGGCACTGGGAGGGCTGGTGGTCAGCGCAGCGAGCCTGGCTGGCTG  480
  L  G  A  L  C  E  N  T  C  L  L  R  G  F  S  G  G  I  L  A  159
CCTGGGCGCCCTCTGCGAGAACACCTGCCTGTTACGTGGCTTCTCCGGGGGCATCCTTGC  540
  F  L  V  L  E  A  V  A  G  A  L  V  V  A  L  W  G  P  L  Q  179
CTTCCTGGTGCTTGAGGCCGTGGCGGGGGCCCTGGTGGTGGCCCTCTGGGGCCCGCTGCA  600
  D  S  L  E  H  T  L  R  V  A  I  A  H  Y  Q  D  D  P  D  L  199
AGACAGCCTGGAGCACACCCTGCGTGTGGCCATCGCCCACTACCAGGACGACCCAGACCT  660
  R  F  L  L  D  Q  V  Q  L  G  L  R  C  C  G  A  A  S  Y  Q  219
GCGCTTCCTCCTCGACCAAGTCCAGCTCGGGCTGAGGTGCTGCGGAGCTGCCTCCTACCA  720
  D  W  Q  Q  N  L  Y  F  N  C  S  S  P  G  V  Q  A  C  S  L  239
GGACTGGCAGCAGAACCTGTACTTTAACTGCAGCTCCCCCGGGGTGCAGGCCTGCAGCCT  780
  P  A  S  C  C  I  D  P  R  E  D  G  A  S  V  N  D  Q  C  G  259
TCCCGCCTCCTGCTGCATCGACCCCCGCGAAGATGGAGCCTCTGTCAACGACCAGTGCGG  840
  F  G  V  L  R  L  D  A  D  A  A  Q  R  V  V  Y  L  E  G  C  279
CTTCGGGGTCCTGCGCCTGGATGCGGACGCAGCTCAGAGAGTGGTGTACCTGGAGGGCTG  900
  G  P  P  L  R  R  W  L  R  A  N  L  A  A  S  G  G  Y  A  I  299
CGGCCCGCCGCTCCGGCGGTGGCTGCGCGCGAACCTGGCTGCCTCGGGCGGCTACGCAAT  960
  A  V  V  L  L  Q  G  A  E  L  L  L  A  A  R  L  L  G  A  L  319
CGCGGTGGTGCTGCTGCAGGGGGCGGAGCTCCTGCTGGCCGCCCGGCTACTCGGGGCCCT 1020
  A  A  R  S  G  A  A  Y  G  P  G  A  H  G  E  D  R  A  G  P  339
CGCTGCCCGCAGTGGGGCGGCGTACGGCCCCGGAGCGCACGGGGAGGACCGCGCTGGCCC 1080
  Q  S  P  S  P  G  A  P  P  A  A  K  P  A  R  G  *           355
CCAGAGCCCCAGCCCCGGCGCCCCGCCCGCTGCCAAACCCGCCCGGGGCTGAgcgcacgc 1140
cccgaggtccgagaccgccacgcacagggatacagggggcgcctccgcccggctaaaaag 1200
cgctgcctgcgccgccgccgccgcctgatttcgctcgggcttcgggtgacttcgccgcag 1260
gacctacccagctcgctcacttcgctcgctccgcgtcccccatgccagcccccaacgcag 1320
ggcgcccggcgaagccacgggactggcgggaggagcacgcggggccggaggaaatcctgg 1380
agctgaccctcacctccgagcccccactcccaccccagccgcacagttcccacctcctgg 1440
cacctccctcccctggggccgccaccccttctgggctcgtgatggtggagctaaggtcca 1500
ggcctctccctcccgagtgcatttttggggagatagtaaatgttttattcgggtgtatca 1560
ttcatacagtaaagacaccaatcttcaaaaaaaaaaaaaaa                    1601

Wistow, Mol Vis 2002; 8:205-220 <http://www.molvis.org/molvis/v8/a27/>
©2002 Molecular Vision <http://www.molvis.org/molvis/>
ISSN 1090-0535